3D Cell Culture Market Size (USD 8.3 Billion by 2031): Growth Prospects, Innovations, and Competitive Landscape to 2032

September 19, 2024 04:04 PM AEST | By EIN Presswire
 3D Cell Culture Market Size (USD 8.3 Billion by 2031): Growth Prospects, Innovations, and Competitive Landscape to 2032
Image source: EIN Presswire

The 3D cell cultures system has an important role in nurturing organoids and functional tissue constructs for transplantation and drug analysis responses. PORTLAND, OR, UNITED STATES, September 19, 2024 /EINPresswire.com/ -- Allied Market Research has published a study report with the title 𝟑𝐃 𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 was Valued at 𝐔𝐒𝐃 𝟏.𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏 and is estimated to surpass around 𝐔𝐒𝐃 𝟖.𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, registering revenue 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟖.𝟐% from 2022 to 2031.

𝐖𝐡𝐚𝐭 𝐢𝐬 𝟑𝐃 𝐜𝐞𝐥𝐥 𝐜𝐮𝐥𝐭𝐮𝐫𝐞?

3D cell culture refers to a method of growing cells in three-dimensional environments that more closely mimic the in vivo conditions found in living organisms, compared to traditional two-dimensional cell culture techniques. In 3D cell culture, cells are grown in a scaffold or matrix that provides a three-dimensional structure for the cells to attach to and interact with. This can allow for better cell-to-cell communication, nutrient and oxygen exchange, and tissue organization, which may lead to more physiologically relevant cellular responses and behavior. 3D cell culture techniques are commonly used in areas such as drug discovery, tissue engineering, and regenerative medicine.

The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/1474

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐭𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞 𝟑𝐃 𝐜𝐞𝐥𝐥 𝐜𝐮𝐥𝐭𝐮𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭?

• Growing adoption of 3D cell culture over traditional 2D cell culture techniques
• Increasing use of spheroids and organoids in drug discovery and development
• Advancements in technology and automation of 3D cell culture systems
• Rising demand for personalized medicine and tissue engineering applications
• Growing investments in research and development activities related to 3D cell culture
• Emergence of 3D bioprinting technologies for organ and tissue engineering
• Growing preference for microfluidic-based 3D cell culture systems for high-throughput screening
• Increasing demand for contract research organizations (CROs) and academic research institutes for 3D cell culture services
• Growing interest in 3D cell culture models for disease modeling and toxicity testing
• Rising demand for 3D cell culture consumables, such as scaffold and hydrogel materials, cell culture plates, and microcarriers.

𝐓𝐨𝐩 𝟑𝐃 𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• 3D Biotek LLC
• Advanced Biomatrix, Inc.
• Avantor, Inc.
• Becton, Dickinson And Company
• Corning Incorporated
• InSphero AG
• Lonza Group Ltd.
• Merck &Co., Inc.
• Synthecon
• Incorporated
• Thermo Fisher Scientific Inc.

𝟑𝐃 𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

The report offers a detailed segmentation of the global 3D cell culture market based on product, application, end-user, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.

Based on product, the scaffold based platforms segment held the largest share in 2021, contributing to around two-fifths of the global 3D cell culture market, and is likely to maintain its leadership status during the forecast period. Moreover, the microchips segment is expected to manifest the highest CAGR of 21.3% from 2022 to 2031. The research also analyzes the segments such as scaffold-free platforms, gels, bioreactors, and services.

Based on application, the cancer research segment held the largest share in 2021, accounting for nearly one-third of the global 3D cell culture market, and would rule the roost through 2031. However, the regenerative medicine segment is estimated to witness the fastest CAGR of 19.5% during the forecast period. The study also encompasses the segments such as stem cell research and drug discovery.

Based on end user, the academic institutes segment was largest market in 2021, accounting for more than one-third of the global 3D cell culture market, and is likely to maintain its leadership status during the forecast period. The contract research laboratories segment, on the other hand, is expected to manifest the highest CAGR of 18.8% from 2022 to 2031. The research also analyzes the biotechnology and pharmaceutical companies segment.

Based on region, North America accounted for the highest share in 2021, contributing to around two-fifths of the global 3D cell culture market, and is likely to dominate the market during the forecasted timeframe. However, Asia-Pacific is projected to portray the fastest CAGR of 19.8% during the forecast period. The research also analyzes the regions including Europe and LAMEA.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/1474

Key findings of the study

• By product, microchips segment is expected to grow at the highest CAGR of 21.3% during the forecast period.
• By end user, the academic institutes segment accounted for nearly half of the share of the global 3D Cell Culture industry in 2020.
• Region-wise, Asia Pacific is expected to experience growth at the highest rate, registering a CAGR of 19.8% during the 3D cell culture market forecast period.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
[email protected]

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.